IL99715A - Pharmaceutical preparations containing a history of indulgence are used - Google Patents
Pharmaceutical preparations containing a history of indulgence are usedInfo
- Publication number
- IL99715A IL99715A IL9971591A IL9971591A IL99715A IL 99715 A IL99715 A IL 99715A IL 9971591 A IL9971591 A IL 9971591A IL 9971591 A IL9971591 A IL 9971591A IL 99715 A IL99715 A IL 99715A
- Authority
- IL
- Israel
- Prior art keywords
- headache
- compound
- treatment
- withdrawal
- use according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909022250A GB9022250D0 (en) | 1990-10-12 | 1990-10-12 | Medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
IL99715A0 IL99715A0 (en) | 1992-08-18 |
IL99715A true IL99715A (en) | 1996-01-19 |
Family
ID=10683660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL9971591A IL99715A (en) | 1990-10-12 | 1991-10-11 | Pharmaceutical preparations containing a history of indulgence are used |
Country Status (16)
Country | Link |
---|---|
US (1) | US5376672A (de) |
EP (1) | EP0552205B1 (de) |
JP (1) | JP3159263B2 (de) |
KR (1) | KR0178762B1 (de) |
AT (1) | ATE168006T1 (de) |
AU (1) | AU660153B2 (de) |
CA (1) | CA2093527A1 (de) |
DE (1) | DE69129750T2 (de) |
DK (1) | DK0552205T3 (de) |
ES (1) | ES2118090T3 (de) |
GB (1) | GB9022250D0 (de) |
IE (1) | IE913580A1 (de) |
IL (1) | IL99715A (de) |
TW (1) | TW212756B (de) |
WO (1) | WO1992006688A1 (de) |
ZA (1) | ZA918117B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1147776B1 (de) * | 1993-12-28 | 2010-12-15 | Allergan, Inc. | Verwendung von Botulinumtoxin Typ B zur Herstellung eines Medikaments zur Behandlung von Muskelkrämpfen |
EP1609477B1 (de) * | 1994-12-12 | 2011-11-09 | Omeros Corporation | Bespüllungslösung und deren Verwendung zur perioperativen Hemmung von Schmerzen, Entzündungen und/oder Spasmen an einer Gefässstruktur |
US20040068000A1 (en) * | 2002-10-02 | 2004-04-08 | Mintong Guo | Compression coated tablets |
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
WO2005123043A2 (en) * | 2004-06-10 | 2005-12-29 | Duramed Pharmaceuticals, Inc. | Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same |
SI2124556T1 (sl) | 2006-10-09 | 2015-01-30 | Charleston Laboratories, Inc. | Farmacevtske sestave |
US8124126B2 (en) | 2008-01-09 | 2012-02-28 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
US8304179B2 (en) * | 2009-05-11 | 2012-11-06 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for manufacturing a semiconductor device using a modified photosensitive layer |
US20100287502A1 (en) * | 2009-05-11 | 2010-11-11 | Olympus Imaging Corp. | Image search device and image search method |
EP2451274B1 (de) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmazeutische zusammensetzungen |
JP2019507181A (ja) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ,インコーポレイテッド | 医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW19381A1 (en) * | 1980-08-12 | 1983-03-09 | Glaxo Group Ltd | Heterocyclic compounds |
GR79215B (de) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
GB8332437D0 (en) * | 1983-12-06 | 1984-01-11 | Glaxo Group Ltd | Chemical compounds |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
GB8419575D0 (en) * | 1984-08-01 | 1984-09-05 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-10-12 GB GB909022250A patent/GB9022250D0/en active Pending
-
1991
- 1991-10-11 WO PCT/GB1991/001768 patent/WO1992006688A1/en active IP Right Grant
- 1991-10-11 DE DE69129750T patent/DE69129750T2/de not_active Expired - Fee Related
- 1991-10-11 KR KR1019930701093A patent/KR0178762B1/ko not_active IP Right Cessation
- 1991-10-11 DK DK91917473T patent/DK0552205T3/da active
- 1991-10-11 EP EP91917473A patent/EP0552205B1/de not_active Expired - Lifetime
- 1991-10-11 ZA ZA918117A patent/ZA918117B/xx unknown
- 1991-10-11 ES ES91917473T patent/ES2118090T3/es not_active Expired - Lifetime
- 1991-10-11 IL IL9971591A patent/IL99715A/en not_active IP Right Cessation
- 1991-10-11 JP JP51611991A patent/JP3159263B2/ja not_active Expired - Fee Related
- 1991-10-11 AT AT91917473T patent/ATE168006T1/de not_active IP Right Cessation
- 1991-10-11 AU AU86422/91A patent/AU660153B2/en not_active Ceased
- 1991-10-11 CA CA002093527A patent/CA2093527A1/en not_active Abandoned
- 1991-10-11 US US08/030,387 patent/US5376672A/en not_active Expired - Lifetime
- 1991-10-16 IE IE358091A patent/IE913580A1/en not_active Application Discontinuation
- 1991-11-22 TW TW080109170A patent/TW212756B/zh active
Also Published As
Publication number | Publication date |
---|---|
CA2093527A1 (en) | 1992-04-13 |
KR0178762B1 (ko) | 1999-03-20 |
WO1992006688A1 (en) | 1992-04-30 |
IE913580A1 (en) | 1992-04-22 |
JP3159263B2 (ja) | 2001-04-23 |
ZA918117B (en) | 1992-08-26 |
AU8642291A (en) | 1992-05-20 |
JPH06501935A (ja) | 1994-03-03 |
EP0552205B1 (de) | 1998-07-08 |
ATE168006T1 (de) | 1998-07-15 |
IL99715A0 (en) | 1992-08-18 |
ES2118090T3 (es) | 1998-09-16 |
AU660153B2 (en) | 1995-06-15 |
GB9022250D0 (en) | 1990-11-28 |
DE69129750D1 (de) | 1998-08-13 |
EP0552205A1 (de) | 1993-07-28 |
US5376672A (en) | 1994-12-27 |
TW212756B (de) | 1993-09-11 |
DK0552205T3 (da) | 1999-04-19 |
DE69129750T2 (de) | 1998-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4925074B2 (ja) | ミルタザピンと1種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物 | |
US4507323A (en) | Treatment of psychosexual dysfunctions | |
AU737086B2 (en) | Butyrate derivatives in the treatment of fibromyalgia and chronic fatigue syndrome | |
US8673979B2 (en) | Pharmaceutical compositions for headache, migraine, nausea and emesis | |
EP0226266B1 (de) | Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln | |
CA2053190C (en) | Preparation of medicaments for treating asthma using (s)-o-fluoromethyl-histidine and esters thereof | |
JP3984787B2 (ja) | 機能性及び/又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用 | |
US5506270A (en) | Venlafaxine in the treatment of hypothalamic amenorrhea in non-depressed women | |
EP0552205B1 (de) | Neue medizinische anwendung eines gewissen indolderivates und dieses enthaltende pharmazeutische zubereitung | |
US20130079304A1 (en) | Pharmaceutical Compositions for the Treatment of Fungal Infections | |
US5693654A (en) | Medicaments for treating intraocular pressure | |
AU619420B2 (en) | Treatment of depression | |
EP0171227B1 (de) | Verwendung von Propiophenon-Verbindung | |
US20090306204A1 (en) | Pharmaceutical Composition Comprising Cyclobenzaprine and Aceclofenac in Association | |
ES2214305T3 (es) | Utilizacion de la ciamemazina en el tratamiento de la eliminacion brusca de las benzodiazepinas. | |
AU658169B2 (en) | Pharmaceutical composition containing granisetron and dexamethasone | |
JP2004513916A (ja) | 複合的な5−ht1aアゴニストおよび選択的セロトニン再取り込み阻害剤の新規な使用 | |
RU2275905C2 (ru) | Фармацевтические композиции от головной боли, мигрени, тошноты и рвоты | |
Cazzola | Pharmacological Treatment Strategies in Stable Chronic Obstructive Pulmonary Disease | |
WO2005077371A1 (en) | Use of levocetirizine for the preparation of a drug | |
MXPA97004579A (en) | Pharmaceutical composition comprising mirtazapine and one or more selective seroton reabsorption inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |